Shaoyu Xie
Research Subjects
Research Interests
Shaoyu Xie has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Danni Wang
Department of Health Promotion and Behavioral Sciences, School of Public Health, Anhui Medical University
1 shared publication - Honghua Zhang
Department of Nutrition, Center for Big Data and Population Health of IHM School of Public Health, Anhui Medical University Hefei Anhui China
1 shared publication - Hongjuan Cao
Department of Chronic Non-communicable Diseases Prevention and Control, Lu’an Municipal Center for Disease Control and Prevention, Lu’an, China (H.C.).
1 shared publication - Shaoxian Liang
Anhui Medical University
1 shared publication - Wanshui Yang
Department of Nutrition, Center for Big Data and Population Health of IHM, School of Public Health, Anhui Medical University, Hefei, China
1 shared publication - Xiaoyu Zhang
Department of Physical Examination Center The First Affiliated Hospital of Anhui Medical University Hefei Anhui China
1 shared publication
Latest Publications
- Open Access
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e034126
Urinary Equol and Equol‐Predicting Microbial Species Are Favorably Associated With Cardiometabolic Risk Markers in Chinese Adults
Background: The association between soy isoflavones intake and cardiometabolic health remains inconclusive. We investigated the associations of urinary biomarkers of isoflavones including daidzein, glycitein, genistein, equol (a gut microbial metabolite of daidzein), and equol‐predicting microbial species with cardiometabolic risk markers. Methods and Results: In a 1‐year study of 305 Chinese community‐dwelling adults aged ≥18 years, urinary isoflavones, fecal microbiota, blood pressure, blood glucose and lipids, and anthropometric data were measured twice, 1 year apart. Brachial‐ankle pulse wave velocity was also measured after 1 year. A linear mixed‐effects model was used to analyze repeated measurements. Logistic regression was used to calculate the adjusted odds ratio (aOR) and 95% CI for the associations for arterial stiffness. Each 1 μg/g creatinine increase in urinary equol concentrations was associated with 1.47%, 0.96%, and 3.32% decrease in triglycerides, plasma atherogenic index, and metabolic syndrome score, respectively (all P P =0.025). Urinary equol was also associated with lower risk of arterial stiffness (aOR, 0.28 [95% CI, 0.09–0.90]; P trend =0.036). We identified 21 bacterial genera whose relative abundance was positively associated with urinary equol (false discovery rate‐corrected P P <0.05). Conclusions: Our findings suggest that urinary equol and equol‐predicting microbial species may improve cardiometabolic risk parameters in Chinese adults.
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e034126
Open AccessUrinary Equol and Equol‐Predicting Microbial Species Are Favorably Associated With Cardiometabolic Risk Markers in Chinese Adults
Background: The association between soy isoflavones intake and cardiometabolic health remains inconclusive. We investigated the associations of urinary biomarkers of isoflavones including daidzein, glycitein, genistein, equol (a gut microbial metabolite of daidzein), and equol‐predicting microbial species with cardiometabolic risk markers. Methods and Results: In a 1‐year study of 305 Chinese community‐dwelling adults aged ≥18 years, urinary isoflavones, fecal microbiota, blood pressure, blood glucose and lipids, and anthropometric data were measured twice, 1 year apart. Brachial‐ankle pulse wave velocity was also measured after 1 year. A linear mixed‐effects model was used to analyze repeated measurements. Logistic regression was used to calculate the adjusted odds ratio (aOR) and 95% CI for the associations for arterial stiffness. Each 1 μg/g creatinine increase in urinary equol concentrations was associated with 1.47%, 0.96%, and 3.32% decrease in triglycerides, plasma atherogenic index, and metabolic syndrome score, respectively (all P P =0.025). Urinary equol was also associated with lower risk of arterial stiffness (aOR, 0.28 [95% CI, 0.09–0.90]; P trend =0.036). We identified 21 bacterial genera whose relative abundance was positively associated with urinary equol (false discovery rate‐corrected P P <0.05). Conclusions: Our findings suggest that urinary equol and equol‐predicting microbial species may improve cardiometabolic risk parameters in Chinese adults.